Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study

Long, G.V. ; Flaherty, K.T. ; Stroyakovskiy, D. ; Gogas, H. ; Levchenko, E. ; de Braud, F. ; Larkin, J. ; Garbe, C. ; Jouary, T. ; Hauschild, A. ; Chiarion-Sileni, V. ; Lebbe, C. ; Mandalà, M. ; Millward, M. ; Arance, A. ; Bondarenko, I. ; Haanen, J.B.A.G. ; Hansson, J. ; Utikal, J. ; Ferraresi, V. ; Mohr, P. ; Probachai, V. ; Schadendorf, D. ; Nathan, P. ; Robert, C. ; Ribas, A. ; Davies, M.A. ; Lane, S.R. ; Legos, J.J. ; Mookerjee, B. ; Grob, J.-J.

Annals of oncology, 2017-07, Vol.28 (7), p.1631-1639 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível